An Official ATS Statement: Hepatotoxicity of Antituberculosis Therapy-Reference-Cited by-同舟云学术

An Official ATS Statement: Hepatotoxicity of Antituberculosis Therapy

Published:2006-10-15 Issue:8 Volume:174 Page:935-952
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Saukkonen Jussi J.,Cohn David L.,Jasmer Robert M.,Schenker Steven,Jereb John A.,Nolan Charles M.,Peloquin Charles A.,Gordin Fred M.,Nunes David,Strader Dorothy B.,Bernardo John,Venkataramanan Raman,Sterling Timothy R.

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference176 articles.

1. Molecular Alterations in Hepatocyte Transport Mechanisms in Acquired Cholestatic Liver Disorders

2. Criteria of drug-induced liver disorders

3. Epidemiology and Individual Susceptibility to Adverse Drug Reactions Affecting the Liver

4. Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States

5. Safety of Nonsteroidal Anti-inflammatory Drugs With Respect to Acute Liver Disease

Cited by 883 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-induced liver injury in tropical settings;Treatment and Management of Tropical Liver Disease;2025

2. Pharmacology of emerging drugs for the treatment of multi-drug resistant tuberculosis;Journal of Clinical Tuberculosis and Other Mycobacterial Diseases;2024-12

3. Diagnosis, prevention and risk-management of drug-induced liver injury due to medications used to treat mycobacterium tuberculosis;Expert Opinion on Drug Safety;2024-09-04

4. Genetic ancestry proportion influences risk of adverse events from tuberculosis treatment in Brazil;2024-08-30

5. Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions;Nature Reviews Gastroenterology & Hepatology;2024-08-15